Vitamin D status in children with epilepsy treated with levetiracetam monotherapy

Epilepsy Res. 2018 Dec:148:116. doi: 10.1016/j.eplepsyres.2018.09.003.

Authors

Achilleas Attilakos¹, Maria Tsirouda², Argiris Dinopoulos², Alexia Prasouli, Anastasia Garoufi³

Affiliations

¹ Third Department of Pediatrics, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece. Electronic address: attilakos@hotmail.com.
² Third Department of Pediatrics, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.
³ Second Department of Pediatrics, National and Kapodistrian University of Athens, "Panagiotis and Aglaia Kyriakou" Children's Hospital, Athens, Greece.

PMID: 30409460
DOI: 10.1016/j.eplepsyres.2018.09.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Child
Epilepsy
Humans
Levetiracetam*
Piracetam
Valproic Acid*
Vitamin D
Vitamin D Deficiency

Substances

Vitamin D
Levetiracetam
Valproic Acid
Piracetam